Cardlytics (NASDAQ:CDLX) CEO Sells $83,101.27 in Stock

Cardlytics, Inc. (NASDAQ:CDLX) CEO Amit Gupta sold 69,833 shares of Cardlytics stock in a transaction that occurred on Monday, April 6th. The shares were sold at an average price of $1.19, for a total value of $83,101.27. Following the completion of the transaction, the chief executive officer owned 987,387 shares in the company, valued at $1,174,990.53. This trade represents a 6.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Amit Gupta also recently made the following trade(s):

• On Thursday, April 2nd, Amit Gupta sold 54,225 shares of Cardlytics stock. The shares were sold at an average price of $1.04, for a total value of $56,394.00.
• On Wednesday, April 1st, Amit Gupta sold 62,549 shares of Cardlytics stock. The shares were sold at an average price of $0.99, for a total value of $61,923.51.
• On Wednesday, February 18th, Amit Gupta sold 45,159 shares of Cardlytics stock. The stock was sold at an average price of $0.93, for a total value of $41,997.87.
• On Tuesday, February 17th, Amit Gupta sold 52,049 shares of Cardlytics stock. The stock was sold at an average price of $0.90, for a total value of $46,844.10.

Cardlytics Stock Down 8.7%

Shares of NASDAQ:CDLX opened at $1.05 on Thursday. Cardlytics, Inc. has a 52-week low of $0.66 and a 52-week high of $3.28. The stock’s fifty day simple moving average is $0.90 and its 200-day simple moving average is $1.31. The company has a market capitalization of $57.82 million, a P/E ratio of -0.54 and a beta of 0.91.

Cardlytics (NASDAQ:CDLX) last released its earnings results on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The business had revenue of $56.10 million during the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative net margin of 44.36% and a negative return on equity of 370.98%. On average, sell-side analysts anticipate that Cardlytics, Inc. will post -1.52 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have commented on CDLX shares. Evercore set a $1.00 target price on Cardlytics in a report on Friday, March 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Cardlytics in a report on Monday, December 29th. Bank of America reaffirmed an “underperform” rating on shares of Cardlytics in a report on Thursday, March 5th. Finally, Wall Street Zen raised Cardlytics from a “sell” rating to a “hold” rating in a report on Saturday, April 4th. Two research analysts have rated the stock with a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, Cardlytics has an average rating of “Reduce” and a consensus price target of $1.75.

Hedge Funds Weigh In On Cardlytics

Hedge funds have recently modified their holdings of the company. Citizens Financial Group Inc. RI acquired a new stake in shares of Cardlytics in the third quarter worth $1,260,000. Quinn Opportunity Partners LLC boosted its position in shares of Cardlytics by 900.0% in the third quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company’s stock worth $2,673,000 after buying an additional 990,000 shares during the period. Barclays PLC boosted its position in Cardlytics by 31,167.6% during the fourth quarter. Barclays PLC now owns 55,969 shares of the company’s stock valued at $64,000 after purchasing an additional 55,790 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in Cardlytics during the fourth quarter valued at $62,000. Finally, Qube Research & Technologies Ltd acquired a new stake in Cardlytics during the third quarter valued at $55,000. 68.10% of the stock is currently owned by institutional investors and hedge funds.

Cardlytics Company Profile

Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers’ online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.

At the core of Cardlytics’ offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.